Clinical Trials on Pulmonary Alveolar Proteinosis in New Zealand
Total 1024 results
-
Savara Inc.Active, not recruitingAutoimmune Pulmonary Alveolar ProteinosisUnited States, Korea, Republic of, United Kingdom, Netherlands, Australia, Romania, Japan, Portugal, Canada, Greece, Spain, Italy, Poland, Belgium, France, Germany, Ireland, Turkey
-
Savara Inc.CompletedAutoimmune Pulmonary Alveolar ProteinosisUnited States, United Kingdom, Denmark, Switzerland, Australia, Portugal, Italy, Greece, Netherlands, Japan, Germany, France, Israel, Korea, Republic of, Russian Federation, Slovakia, Spain, Turkey
-
Mylan Inc.Theravance BiopharmaCompletedChronic Obstructive Pulmonary Disease, COPDNew Zealand
-
Mylan Inc.Theravance BiopharmaCompleted
-
Middlemore Hospital, New ZealandUnknownPulmonary Parenchymal LesionsNew Zealand
-
Waikato HospitalWaikato Hospital Research FundCompletedChronic Obstructive Pulmonary DiseaseNew Zealand
-
University of Auckland, New ZealandTerminatedSmoking Cessation | Chronic Obstructive Pulmonary DiseaseNew Zealand
-
InSilico Medicine Hong Kong LimitedCompletedA Phase 1, Evaluate the Safety, Tolerability, and Pharmacokinetics of INS018_055 in Healthy SubjectsIdiopathic Pulmonary FibrosisNew Zealand
-
University of OtagoHealth Research Council, New ZealandCompleted
-
Fisher and Paykel HealthcareMedical Research Institute of New Zealand; Alana HealthcareTerminatedChronic Obstructive Pulmonary Disease | COPDUnited States, New Zealand
-
GlaxoSmithKlineCompleted
-
VenitiWithdrawnDeep Vein Thrombosis | Pulmonary EmbolusNew Zealand, Australia
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseAustralia, New Zealand
-
Arrowhead PharmaceuticalsRecruitingIdiopathic Pulmonary FibrosisDenmark, New Zealand, Spain
-
Mundipharma Research LimitedCompletedChronic Obstructive Pulmonary DiseaseChina, Taiwan, Korea, Republic of, New Zealand, Australia
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveAustralia, New Zealand
-
Theravance BiopharmaGlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveThailand, New Zealand, United Kingdom
-
Crux BiomedicalCompletedPulmonary EmbolismNew Zealand, Australia
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveArgentina, Chile, South Africa, New Zealand
-
Stony Brook UniversityUnknownAlveolar Ridge AugmentationUnited States
-
Algernon PharmaceuticalsCompletedIdiopathic Pulmonary FibrosisAustralia, New Zealand
-
Teva Branded Pharmaceutical Products R&D, Inc.TerminatedStudy in Healthy Volunteers and COPD Patients to Evaluate the Efficacy and Safety of Inhaled TV46017Chronic Obstructive Pulmonary Disease (COPDUnited States, Australia, New Zealand
-
Biosplice Therapeutics, Inc.WithdrawnIdiopathic Pulmonary FibrosisAustralia, New Zealand
-
Louisiana State University Health Sciences Center...RecruitingInferior Alveolar Nerve | Mandibular Nerve BlocksUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.TerminatedChronic Obstructive Pulmonary DiseaseUnited States, Australia, New Zealand
-
The George InstituteActive, not recruitingCardiovascular Diseases | Chronic Obstructive Pulmonary DiseaseAustralia, New Zealand
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveAustralia, New Zealand
-
Arrowhead PharmaceuticalsTerminatedCystic Fibrosis, PulmonaryAustralia, New Zealand
-
Children's Oncology GroupNational Cancer Institute (NCI)RecruitingEmbryonal Rhabdomyosarcoma | Fusion-Negative Alveolar Rhabdomyosarcoma | Spindle Cell/Sclerosing RhabdomyosarcomaUnited States, Australia, Canada, New Zealand
-
National Cancer Institute (NCI)RecruitingMetastatic Alveolar Soft Part Sarcoma | Unresectable Alveolar Soft Part SarcomaUnited States
-
Louisiana State University Health Sciences Center...RecruitingAlveolar Ridge DeficiencyUnited States
-
NovartisCompletedChronic Obstructive Pulmonary Disease (COPD)Spain, Germany, South Africa, Australia, Poland, New Zealand, Netherlands
-
Monash Medical CentreMiddlemore Hospital, New Zealand; Prince of Wales Hospital, Sydney; Auckland... and other collaboratorsUnknownVenous Thrombosis | Pulmonary EmbolismAustralia, New Zealand
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveAustralia, New Zealand, United Kingdom
-
National Cancer Institute (NCI)CompletedStage IV Adult Soft Tissue Sarcoma | Adult Rhabdomyosarcoma | Metastatic Childhood Soft Tissue Sarcoma | Childhood Alveolar Rhabdomyosarcoma | Childhood Embryonal Rhabdomyosarcoma | Untreated Childhood RhabdomyosarcomaUnited States, Canada, Australia, New Zealand
-
National Cancer Institute (NCI)CompletedRecurrent Childhood Rhabdomyosarcoma | Recurrent Adult Soft Tissue Sarcoma | Previously Treated Childhood Rhabdomyosarcoma | Adult Rhabdomyosarcoma | Childhood Alveolar Rhabdomyosarcoma | Childhood Pleomorphic Rhabdomyosarcoma | Childhood Rhabdomyosarcoma With Mixed Embryonal and Alveolar FeaturesUnited States, Canada, Australia, New Zealand
-
McMaster UniversityHeart and Stroke Foundation of OntarioCompletedDeep Vein Thrombosis | Venous Thromboembolism | Pulmonary EmbolismCanada, New Zealand
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseAustralia, United States, New Zealand
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveAustralia, Romania, Bulgaria, Germany, Netherlands, New Zealand
-
Flinders UniversityCompletedChronic Obstructive Pulmonary Disease | DyspneaAustralia, New Zealand
-
Arrowhead PharmaceuticalsRecruitingChronic Obstructive Pulmonary Disease | AsthmaKorea, Republic of, Australia, New Zealand, Poland, Thailand, Spain
-
Memorial Sloan Kettering Cancer CenterRecruitingSarcoma | Undifferentiated Pleomorphic Sarcoma | Alveolar Soft Part Sarcoma | MyxofibrosarcomaUnited States
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States, Australia, New Zealand
-
Aquinox Pharmaceuticals (Canada) Inc.CompletedCOPDUnited States, New Zealand, Poland, Australia, Denmark, Finland, Hungary, Sweden
-
DeyCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
Children's Oncology GroupNational Cancer Institute (NCI)RecruitingAlveolar Rhabdomyosarcoma | Embryonal Rhabdomyosarcoma | Botryoid-Type Embryonal Rhabdomyosarcoma | Spindle Cell Rhabdomyosarcoma | Spindle Cell/Sclerosing Rhabdomyosarcoma | Metastatic Embryonal Rhabdomyosarcoma | Metastatic Rhabdomyosarcoma | Solid Alveolar RhabdomyosarcomaUnited States, Canada, Australia, Puerto Rico, Saudi Arabia
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany, Sweden, New Zealand, Russian Federation, United Kingdom
-
National Cancer Institute (NCI)Active, not recruitingRhabdomyosarcoma | Alveolar Rhabdomyosarcoma | Embryonal Rhabdomyosarcoma | Botryoid-Type Embryonal Rhabdomyosarcoma | Sclerosing Rhabdomyosarcoma | Spindle Cell RhabdomyosarcomaUnited States, Canada, Puerto Rico, Australia, New Zealand
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Epix Pharmaceuticals, Inc.CompletedChronic Obstructive Pulmonary Disease | Pulmonary HypertensionUnited States